Accueil
A partir de cette page vous pouvez :
Retourner au premier écran avec les dernières notices... |
Résultat de la recherche
1 résultat(s) recherche sur le mot-clé 'Cardite rhumatismale chronique'
Affiner la recherche Faire une suggestion
Titre : STREPTOCOCCIE ET RHUMATISME ARTICULAIRE AIGU Type de document : thèse Auteurs : Asmae BOUKIOUD, Auteur Année de publication : 2021 Langues : Français (fre) Mots-clés : Cardite rhumatismale chronique Infection Prophylaxie Rhumatisme articulaire aigu Streptococcus Résumé : Keywords: Chronic rheumatic heart disease, Infection, Prophylaxis, Acute rheumatic
fever, Streptococcus.
Streptococci are gram-positive, catalase-negative, facultative anaerobic bacteria that
require enriched media for growth. Their bacteriological diagnosis is made by direct method
(identification of the germ) and by indirect method (antibody assay).
The different species of the genus Streptococcus, pathogenic to humans, are the cause of
several infections with variable severity.
Acute rheumatic fever (ARF) is a post-streptococcal non-suppurative autoimmune
inflammatory complication that occurs 2-4 weeks after an inadequately treated or untreated
group A β-hemolytic streptococcal (GAS) infection. It affects mostly children between the
ages of 5 and 14 years. It’s a public health problem in Morocco, as well as in developing
countries.
Clinically, it’s manifested by joint, cardiac, neurological and skin disorders. The
prognosis is conditioned by the severity of the cardiac lesions which may evaluate to a chronic
rheumatic heart disease (RHD). The risk of occurrence and aggravation of RHD is high with
each recurrent episode of ARF.
Its diagnosis is based on the Jones criteria recently modified in 2015 and which requires
evidence of recent GAS infection. Echocardiography is essential for the diagnosis and followup of the disease.
Therapeutic management of a rheumatic episode is based on anti-inflammatory drugs
and antibiotic therapy. However, the best way to manage this pathology is through primordial
prevention by the improvement of living conditions, as well as primary and secondary
prevention.Numéro (Thèse ou Mémoire) : M3162021 Président : Mimoun ZOUHDI Directeur : Yassine SEKHSOKH Juge : Ahmed GAOUZI Juge : Saida TELLAL STREPTOCOCCIE ET RHUMATISME ARTICULAIRE AIGU [thèse] / Asmae BOUKIOUD, Auteur . - 2021.
Langues : Français (fre)
Mots-clés : Cardite rhumatismale chronique Infection Prophylaxie Rhumatisme articulaire aigu Streptococcus Résumé : Keywords: Chronic rheumatic heart disease, Infection, Prophylaxis, Acute rheumatic
fever, Streptococcus.
Streptococci are gram-positive, catalase-negative, facultative anaerobic bacteria that
require enriched media for growth. Their bacteriological diagnosis is made by direct method
(identification of the germ) and by indirect method (antibody assay).
The different species of the genus Streptococcus, pathogenic to humans, are the cause of
several infections with variable severity.
Acute rheumatic fever (ARF) is a post-streptococcal non-suppurative autoimmune
inflammatory complication that occurs 2-4 weeks after an inadequately treated or untreated
group A β-hemolytic streptococcal (GAS) infection. It affects mostly children between the
ages of 5 and 14 years. It’s a public health problem in Morocco, as well as in developing
countries.
Clinically, it’s manifested by joint, cardiac, neurological and skin disorders. The
prognosis is conditioned by the severity of the cardiac lesions which may evaluate to a chronic
rheumatic heart disease (RHD). The risk of occurrence and aggravation of RHD is high with
each recurrent episode of ARF.
Its diagnosis is based on the Jones criteria recently modified in 2015 and which requires
evidence of recent GAS infection. Echocardiography is essential for the diagnosis and followup of the disease.
Therapeutic management of a rheumatic episode is based on anti-inflammatory drugs
and antibiotic therapy. However, the best way to manage this pathology is through primordial
prevention by the improvement of living conditions, as well as primary and secondary
prevention.Numéro (Thèse ou Mémoire) : M3162021 Président : Mimoun ZOUHDI Directeur : Yassine SEKHSOKH Juge : Ahmed GAOUZI Juge : Saida TELLAL Réservation
Réserver ce document
Exemplaires
Code barre Cote Support Localisation Section Disponibilité M3162021 WA Thèse imprimé Unité des Thèses et Mémoires ThèsesMéd2021 Disponible M3162021-1 WA Thèse imprimé Unité des Thèses et Mémoires ThèsesMéd2021 Disponible Documents numériques
M3162021URL